Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$205.79 USD
-3.83 (-1.83%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $206.04 +0.25 (0.12%) 7:02 PM ET
4-Sell of 5 4
C Value C Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Bottom 35% (162 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.18 | 2.02 | 9.99 |
Current Quarter Estimate | 2.42 | 5.18 | 61.00 |
Year Ago Quarter Estimate | 2.72 | 1.42 | 54.84 |
Next Quarter Estimate | 2.53 | 4.75 | 63.00 |
Next Year Estimate | 10.74 | 26.08 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -6.19 | 7.40 | 15.67 |
Next Year | 7.29 | 18.60 | 11.34 |
Last 5 Years | 12.10 | 9.60 | 8.10 |
Next 5 Years | 5.00 | 13.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 20.45 | -3.10 |
Price/Book (MRQ) | 2.90 | 2.05 |
Price/Cash Flow (MRFY) | 12.47 | 13.48 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 10.83% | -11.31% |
Return on Equity (TTM) | 14.96% | -10.25% |
Debt to Equity (MRQ) | 0.65 | 28.67 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.